-The Hindu Year 2015 will be crucial as shale oil firms begin to feel the pinch of low prices Are falling oil prices good or bad for the global economy? And how do they work for India? Till recently these questions were no-brainers. Cheaper oil is obviously good for the global economy; for an energy-intensive economy such as India's, which also depends on imported oil for meeting four-fifths of its needs, a...

-The Times of India The inflation rate slowed to a more than three-year low of 5.96% in March on the back of softening vegetable, fruits and milk prices, brightening the prospect of an interest rate cut by RBI while bringing relief for the politically beleaguered government. Lower interest rates would provide relief to thousands of borrowers reeling under the burden of high equated monthly installments ( EMIs) on their home loans. Data released...

-Live Mint CCEA clears recommendations on sugar sector made by Rangarajan panel; subsidy burden to rise Pushing ahead with long-pending reforms of the sugar industry, the cabinet on Thursday approved the dismantling of rules requiring sugar mills to sell the sweetener at below-market prices through the public distribution system (PDS) and abolished curbs on open market sale. The cabinet committee on economic affairs cleared the recommendations made by a panel headed by C....

-Live Mint CERC calls for a variable ‘compensatory tariff' to be offered to Adani Power till fuel situation stabilizes In an unprecedented move, India's apex power sector regulator offered a bailout package to Adani Power Ltd in a late Tuesday order to offset losses on account of the unexpected increase in the prices of imported coal and the unavailability of domestic coal for the company's 4,620 megawatts (MW) thermal power project at...

-Live Mint SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness In a landmark judgement, India's apex court rejected Swiss drug maker Novartis AG's legal challenge aimed at securing a patent for blockbuster anti-cancer drug imatinib mesylate, branded Glivec in the country. The verdict, which is seen as a setback to multinational pharmaceutical companies operating in India, may influence a rash of pending disputes...